Aristea Therapeutics
About:
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Website: http://aristeatx.com/
Twitter/X: AristeaTx
Top Investors: Fidelity, Novo Holdings, Arena Pharmaceuticals, Tekla Capital Management
Description:
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.The company's therapies include developing drugs, enabling inflammatory diseases patients to address their unmet medical needs.
Total Funding Amount:
$118M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
San Diego, California, United States
Founded Date:
2018-01-01
Contact Email:
info(AT)aristeatx.com
Founders:
James Mackay
Number of Employees:
1-10
Last Funding Date:
2021-07-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai